| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Erectile Dysfunction | 4 | 2019 | 141 | 2.47 | Why? |
| Phosphodiesterase 5 Inhibitors | 2 | 2019 | 104 | 1.39 | Why? |
| Geologic Sediments | 2 | 2018 | 43 | 1.37 | Why? |
| Seawater | 2 | 2018 | 60 | 1.34 | Why? |
| Metals, Heavy | 2 | 2018 | 147 | 1.19 | Why? |
| Carcinoma, Hepatocellular | 4 | 2018 | 1222 | 1.12 | Why? |
| Infertility, Male | 2 | 2018 | 322 | 1.00 | Why? |
| Liver Neoplasms | 4 | 2018 | 1666 | 0.98 | Why? |
| RNA, Long Noncoding | 2 | 2018 | 408 | 0.98 | Why? |
| Water Pollutants, Chemical | 2 | 2018 | 410 | 0.89 | Why? |
| Serum Globulins | 1 | 2020 | 20 | 0.88 | Why? |
| Carcinoma, Renal Cell | 2 | 2018 | 545 | 0.87 | Why? |
| Magnetic Resonance Imaging | 7 | 2021 | 6551 | 0.86 | Why? |
| Cryptorchidism | 1 | 2019 | 10 | 0.79 | Why? |
| Retroperitoneal Neoplasms | 1 | 2019 | 17 | 0.79 | Why? |
| Caudate Nucleus | 1 | 2018 | 5 | 0.79 | Why? |
| Brain Mapping | 2 | 2018 | 228 | 0.79 | Why? |
| Prostatic Hyperplasia | 2 | 2018 | 161 | 0.78 | Why? |
| Kidney Neoplasms | 2 | 2018 | 832 | 0.77 | Why? |
| Arsenicals | 1 | 2018 | 40 | 0.76 | Why? |
| Adrenergic alpha-Antagonists | 1 | 2018 | 9 | 0.76 | Why? |
| Parietal Lobe | 1 | 2018 | 29 | 0.76 | Why? |
| Penile Erection | 1 | 2019 | 58 | 0.75 | Why? |
| Cerebrum | 1 | 2018 | 17 | 0.75 | Why? |
| Varicocele | 1 | 2018 | 11 | 0.74 | Why? |
| Food Additives | 1 | 2018 | 27 | 0.74 | Why? |
| Meat Products | 1 | 2018 | 39 | 0.73 | Why? |
| Rotavirus | 2 | 2018 | 329 | 0.73 | Why? |
| Temporal Lobe | 1 | 2018 | 83 | 0.73 | Why? |
| Wnt Signaling Pathway | 1 | 2018 | 87 | 0.72 | Why? |
| Testosterone | 3 | 2019 | 596 | 0.72 | Why? |
| Oxides | 1 | 2018 | 77 | 0.72 | Why? |
| Meningitis, Cryptococcal | 1 | 2018 | 79 | 0.71 | Why? |
| Serum Albumin, Human | 1 | 2020 | 265 | 0.71 | Why? |
| Axons | 1 | 2018 | 73 | 0.71 | Why? |
| Anthracenes | 1 | 2017 | 28 | 0.71 | Why? |
| Testicular Neoplasms | 1 | 2019 | 91 | 0.70 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2019 | 106 | 0.70 | Why? |
| AIDS Dementia Complex | 1 | 2018 | 48 | 0.70 | Why? |
| Estuaries | 1 | 2017 | 25 | 0.69 | Why? |
| Luminescent Proteins | 1 | 2017 | 142 | 0.68 | Why? |
| Andrology | 1 | 2019 | 126 | 0.68 | Why? |
| Frontal Lobe | 1 | 2018 | 191 | 0.67 | Why? |
| Simian Acquired Immunodeficiency Syndrome | 1 | 2018 | 154 | 0.67 | Why? |
| Motor Cortex | 1 | 2017 | 71 | 0.67 | Why? |
| Cerebellum | 1 | 2018 | 119 | 0.66 | Why? |
| Lower Urinary Tract Symptoms | 1 | 2018 | 116 | 0.66 | Why? |
| Neural Pathways | 1 | 2018 | 155 | 0.66 | Why? |
| Magnetite Nanoparticles | 1 | 2018 | 109 | 0.65 | Why? |
| AMP-Activated Protein Kinases | 1 | 2017 | 93 | 0.65 | Why? |
| Molecular Probes | 1 | 2018 | 106 | 0.65 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.65 | Why? |
| Hypogonadism | 1 | 2018 | 196 | 0.64 | Why? |
| Hippocampus | 1 | 2018 | 237 | 0.63 | Why? |
| Simian Immunodeficiency Virus | 1 | 2018 | 251 | 0.62 | Why? |
| Cholangiocarcinoma | 1 | 2018 | 186 | 0.61 | Why? |
| Myocardial Reperfusion Injury | 1 | 2017 | 129 | 0.61 | Why? |
| Luciferases | 1 | 2017 | 378 | 0.60 | Why? |
| Nanoparticles | 8 | 2018 | 2040 | 0.60 | Why? |
| Bile Duct Neoplasms | 1 | 2018 | 172 | 0.60 | Why? |
| Bone and Bones | 1 | 2018 | 235 | 0.60 | Why? |
| Androgens | 1 | 2018 | 267 | 0.57 | Why? |
| Environmental Monitoring | 2 | 2018 | 3143 | 0.57 | Why? |
| Rotavirus Infections | 1 | 2018 | 355 | 0.55 | Why? |
| Trace Elements | 1 | 2018 | 284 | 0.54 | Why? |
| Selenium | 1 | 2018 | 412 | 0.52 | Why? |
| Infertility | 1 | 2017 | 247 | 0.51 | Why? |
| Multimodal Imaging | 1 | 2017 | 534 | 0.49 | Why? |
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 1014 | 0.49 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.49 | Why? |
| Cardiovascular Agents | 1 | 2019 | 663 | 0.48 | Why? |
| Macaca mulatta | 3 | 2018 | 3716 | 0.47 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.46 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.44 | Why? |
| Encephalitis | 1 | 2018 | 797 | 0.43 | Why? |
| MicroRNAs | 3 | 2018 | 1787 | 0.43 | Why? |
| Antineoplastic Agents | 4 | 2018 | 3550 | 0.41 | Why? |
| RNA, Small Interfering | 4 | 2018 | 817 | 0.40 | Why? |
| HIV Infections | 3 | 2019 | 11620 | 0.35 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.35 | Why? |
| Drug Carriers | 3 | 2018 | 590 | 0.35 | Why? |
| Gene Expression Regulation | 3 | 2020 | 4020 | 0.33 | Why? |
| Health Status | 2 | 2019 | 3259 | 0.33 | Why? |
| Tomography, X-Ray Computed | 6 | 2021 | 25144 | 0.32 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.32 | Why? |
| Cognitive Dysfunction | 1 | 2018 | 1389 | 0.32 | Why? |
| Medicine, Chinese Traditional | 1 | 2019 | 2255 | 0.31 | Why? |
| Cough | 1 | 2020 | 4891 | 0.31 | Why? |
| Periodicals as Topic | 1 | 2019 | 1492 | 0.30 | Why? |
| Microtubule-Associated Proteins | 1 | 2006 | 187 | 0.30 | Why? |
| Brain Diseases | 1 | 2017 | 1463 | 0.29 | Why? |
| Nanomedicine | 2 | 2018 | 329 | 0.27 | Why? |
| Clinical Decision-Making | 1 | 2018 | 3755 | 0.26 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.26 | Why? |
| Cell Line, Tumor | 5 | 2018 | 3608 | 0.26 | Why? |
| RNA Interference | 1 | 2006 | 534 | 0.26 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Breast Neoplasms | 2 | 2018 | 3633 | 0.24 | Why? |
| Diabetes Mellitus, Type 2 | 3 | 2019 | 6166 | 0.24 | Why? |
| Femur Head Necrosis | 2 | 2019 | 25 | 0.24 | Why? |
| Male | 34 | 2021 | 367725 | 0.24 | Why? |
| Aging | 1 | 2018 | 3581 | 0.23 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.23 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.23 | Why? |
| Research Design | 1 | 2019 | 5830 | 0.23 | Why? |
| Neoplasm Proteins | 1 | 2006 | 501 | 0.22 | Why? |
| Genetic Vectors | 2 | 2018 | 1600 | 0.22 | Why? |
| MCF-7 Cells | 2 | 2018 | 199 | 0.22 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.21 | Why? |
| Gene Ontology | 2 | 2020 | 391 | 0.21 | Why? |
| Humans | 55 | 2021 | 930598 | 0.21 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.21 | Why? |
| China | 10 | 2020 | 50654 | 0.21 | Why? |
| Mice, Nude | 2 | 2018 | 340 | 0.21 | Why? |
| Fibula | 1 | 2019 | 9 | 0.20 | Why? |
| Cancellous Bone | 1 | 2019 | 14 | 0.20 | Why? |
| Thyroid Dysgenesis | 1 | 2019 | 4 | 0.20 | Why? |
| Lymphoid Tissue | 1 | 2020 | 162 | 0.20 | Why? |
| Spatio-Temporal Analysis | 2 | 2018 | 1182 | 0.20 | Why? |
| Bone Transplantation | 1 | 2019 | 38 | 0.20 | Why? |
| Crassostrea | 1 | 2018 | 1 | 0.20 | Why? |
| Polyethylene Glycols | 3 | 2018 | 574 | 0.19 | Why? |
| Animals | 16 | 2018 | 78931 | 0.19 | Why? |
| Glutathione Peroxidase | 1 | 2018 | 83 | 0.19 | Why? |
| Thymidine Kinase | 1 | 2018 | 11 | 0.19 | Why? |
| Adult | 22 | 2020 | 244371 | 0.19 | Why? |
| Cisplatin | 2 | 2018 | 209 | 0.19 | Why? |
| Netrin-1 | 1 | 2018 | 4 | 0.18 | Why? |
| Receptors, Somatomedin | 1 | 2017 | 7 | 0.18 | Why? |
| Prostatitis | 1 | 2018 | 18 | 0.18 | Why? |
| Rheology | 1 | 2018 | 70 | 0.18 | Why? |
| Iodine Radioisotopes | 1 | 2019 | 124 | 0.18 | Why? |
| Alloys | 1 | 2018 | 53 | 0.18 | Why? |
| Color | 1 | 2018 | 92 | 0.18 | Why? |
| Lactones | 1 | 2018 | 62 | 0.18 | Why? |
| Powders | 1 | 2018 | 121 | 0.18 | Why? |
| Septal Occluder Device | 1 | 2018 | 46 | 0.18 | Why? |
| Neovascularization, Physiologic | 1 | 2019 | 160 | 0.18 | Why? |
| Ductus Arteriosus, Patent | 1 | 2018 | 32 | 0.18 | Why? |
| Intestinal Absorption | 1 | 2018 | 64 | 0.18 | Why? |
| CD4-CD8 Ratio | 1 | 2018 | 235 | 0.18 | Why? |
| Coitus | 1 | 2018 | 44 | 0.18 | Why? |
| Graves Disease | 1 | 2019 | 61 | 0.17 | Why? |
| Animals, Newborn | 1 | 2018 | 350 | 0.17 | Why? |
| Chemotherapy, Adjuvant | 2 | 2019 | 606 | 0.17 | Why? |
| Hip Prosthesis | 1 | 2017 | 54 | 0.17 | Why? |
| Transplantation, Heterologous | 1 | 2017 | 77 | 0.17 | Why? |
| Vaginal Neoplasms | 1 | 2017 | 39 | 0.17 | Why? |
| Rhabdomyosarcoma | 1 | 2017 | 15 | 0.17 | Why? |
| Polymers | 3 | 2018 | 507 | 0.17 | Why? |
| Cooking | 1 | 2018 | 144 | 0.17 | Why? |
| Rest | 1 | 2018 | 188 | 0.17 | Why? |
| RNA, Untranslated | 1 | 2018 | 140 | 0.17 | Why? |
| Metals | 1 | 2019 | 182 | 0.17 | Why? |
| Men's Health | 1 | 2018 | 80 | 0.17 | Why? |
| CpG Islands | 1 | 2018 | 230 | 0.16 | Why? |
| HEK293 Cells | 4 | 2018 | 8394 | 0.16 | Why? |
| Cardiovascular Diseases | 2 | 2019 | 11497 | 0.16 | Why? |
| Hep G2 Cells | 1 | 2017 | 391 | 0.16 | Why? |
| DNA Damage | 1 | 2018 | 285 | 0.16 | Why? |
| Salvage Therapy | 1 | 2019 | 417 | 0.16 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.15 | Why? |
| Static Electricity | 1 | 2018 | 397 | 0.15 | Why? |
| Genome | 1 | 2018 | 341 | 0.15 | Why? |
| Uterine Cervical Neoplasms | 2 | 2017 | 842 | 0.15 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2018 | 192 | 0.15 | Why? |
| Chemoprevention | 1 | 2020 | 585 | 0.15 | Why? |
| Intestine, Small | 1 | 2018 | 336 | 0.15 | Why? |
| Principal Component Analysis | 1 | 2018 | 689 | 0.15 | Why? |
| Fluorescence | 1 | 2017 | 475 | 0.15 | Why? |
| Macrophages | 2 | 2018 | 2784 | 0.15 | Why? |
| Adaptation, Physiological | 1 | 2018 | 359 | 0.15 | Why? |
| Confidence Intervals | 1 | 2018 | 744 | 0.15 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1573 | 0.15 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.14 | Why? |
| Wound Healing | 1 | 2019 | 424 | 0.14 | Why? |
| Proteomics | 3 | 2021 | 2481 | 0.14 | Why? |
| Snails | 1 | 2014 | 18 | 0.14 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.14 | Why? |
| Rabbits | 1 | 2018 | 1171 | 0.14 | Why? |
| Gene Editing | 1 | 2018 | 330 | 0.14 | Why? |
| Rats, Sprague-Dawley | 1 | 2017 | 987 | 0.13 | Why? |
| Thyroid Gland | 1 | 2019 | 516 | 0.13 | Why? |
| Testis | 1 | 2019 | 566 | 0.13 | Why? |
| Radiologists | 1 | 2020 | 873 | 0.13 | Why? |
| Cell Culture Techniques | 1 | 2018 | 704 | 0.13 | Why? |
| Genetic Therapy | 1 | 2018 | 409 | 0.13 | Why? |
| Reproductive Techniques, Assisted | 1 | 2018 | 400 | 0.12 | Why? |
| Middle Aged | 18 | 2021 | 270681 | 0.12 | Why? |
| Bentonite | 1 | 2012 | 11 | 0.12 | Why? |
| Fatal Outcome | 2 | 2020 | 3438 | 0.12 | Why? |
| Ecosystem | 1 | 2018 | 776 | 0.12 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Depression | 1 | 2017 | 14116 | 0.12 | Why? |
| Female | 24 | 2021 | 380317 | 0.12 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.12 | Why? |
| Luminescent Measurements | 1 | 2017 | 924 | 0.12 | Why? |
| Arthroplasty, Replacement, Hip | 1 | 2017 | 403 | 0.12 | Why? |
| Sexual Partners | 1 | 2017 | 612 | 0.11 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.11 | Why? |
| Myocardium | 2 | 2021 | 2323 | 0.11 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.11 | Why? |
| Cardiomyopathies | 1 | 2021 | 997 | 0.11 | Why? |
| Lung Injury | 1 | 2020 | 919 | 0.11 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.11 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.11 | Why? |
| Protein Interaction Maps | 1 | 2018 | 1333 | 0.11 | Why? |
| Gene Expression Profiling | 2 | 2020 | 3788 | 0.11 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.10 | Why? |
| Pulmonary Fibrosis | 1 | 2020 | 1068 | 0.10 | Why? |
| Up-Regulation | 1 | 2018 | 2249 | 0.10 | Why? |
| Nanostructures | 1 | 2018 | 700 | 0.10 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.10 | Why? |
| Regression Analysis | 1 | 2018 | 2484 | 0.10 | Why? |
| Interferon-gamma | 1 | 2020 | 2711 | 0.10 | Why? |
| Proteome | 1 | 2020 | 1812 | 0.10 | Why? |
| Hot Temperature | 1 | 2018 | 1299 | 0.10 | Why? |
| Autophagy | 1 | 2017 | 960 | 0.10 | Why? |
| Apoptosis | 4 | 2018 | 2335 | 0.10 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.10 | Why? |
| RNA, Messenger | 2 | 2018 | 5131 | 0.10 | Why? |
| Medication Adherence | 1 | 2019 | 1270 | 0.10 | Why? |
| Insulin | 1 | 2018 | 1316 | 0.09 | Why? |
| Nitrogen Dioxide | 1 | 2012 | 488 | 0.09 | Why? |
| Quality of Life | 3 | 2019 | 9820 | 0.09 | Why? |
| Patient Acceptance of Health Care | 2 | 2017 | 5002 | 0.09 | Why? |
| Follow-Up Studies | 4 | 2021 | 17020 | 0.09 | Why? |
| Artificial Intelligence | 2 | 2020 | 3543 | 0.09 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.09 | Why? |
| Inhibitor of Apoptosis Proteins | 1 | 2006 | 21 | 0.09 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.08 | Why? |
| Drug Liberation | 2 | 2018 | 141 | 0.08 | Why? |
| Signal Transduction | 3 | 2020 | 7207 | 0.08 | Why? |
| Smoking | 2 | 2018 | 3358 | 0.08 | Why? |
| Amides | 1 | 2018 | 1864 | 0.08 | Why? |
| Software | 1 | 2018 | 2501 | 0.08 | Why? |
| Risk Factors | 5 | 2020 | 71621 | 0.08 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.08 | Why? |
| Anti-HIV Agents | 1 | 2019 | 2209 | 0.08 | Why? |
| Treatment Outcome | 5 | 2019 | 51732 | 0.08 | Why? |
| Time Factors | 3 | 2019 | 31397 | 0.08 | Why? |
| Tumor Microenvironment | 2 | 2018 | 264 | 0.08 | Why? |
| Liver | 1 | 2020 | 4007 | 0.08 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.07 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Tissue Distribution | 2 | 2018 | 483 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Transcriptome | 1 | 2018 | 3466 | 0.07 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.07 | Why? |
| Feces | 1 | 2018 | 4235 | 0.07 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Aged | 10 | 2020 | 215776 | 0.07 | Why? |
| Cardiac Surgical Procedures | 1 | 2018 | 1931 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Caco-2 Cells | 2 | 2018 | 1236 | 0.07 | Why? |
| Combined Modality Therapy | 3 | 2018 | 3395 | 0.07 | Why? |
| Fluorescent Antibody Technique | 1 | 2006 | 835 | 0.07 | Why? |
| Beijing | 2 | 2017 | 912 | 0.07 | Why? |
| Hydrogen-Ion Concentration | 2 | 2018 | 993 | 0.07 | Why? |
| Transfection | 1 | 2006 | 864 | 0.07 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4545 | 0.06 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.06 | Why? |
| Computational Biology | 1 | 2018 | 4514 | 0.06 | Why? |
| Lung | 3 | 2020 | 31049 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| HeLa Cells | 1 | 2006 | 1303 | 0.06 | Why? |
| Carcinoma, Squamous Cell | 1 | 2011 | 902 | 0.06 | Why? |
| Influenza, Human | 2 | 2017 | 10779 | 0.06 | Why? |
| Myocardial Infarction | 1 | 2018 | 3361 | 0.06 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.06 | Why? |
| Case-Control Studies | 2 | 2019 | 17671 | 0.06 | Why? |
| Virus Shedding | 1 | 2018 | 5834 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Neoplasms | 4 | 2018 | 17251 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2018 | 5837 | 0.06 | Why? |
| Travel | 1 | 2020 | 7220 | 0.06 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Biopsy, Large-Core Needle | 1 | 2020 | 81 | 0.05 | Why? |
| Finite Element Analysis | 1 | 2019 | 27 | 0.05 | Why? |
| Sex Hormone-Binding Globulin | 1 | 2019 | 57 | 0.05 | Why? |
| Adolescent | 6 | 2020 | 86841 | 0.05 | Why? |
| Postoperative Complications | 1 | 2018 | 5861 | 0.05 | Why? |
| Stress, Mechanical | 1 | 2019 | 143 | 0.05 | Why? |
| In Situ Hybridization | 1 | 2020 | 390 | 0.05 | Why? |
| Metabolic Networks and Pathways | 1 | 2020 | 285 | 0.05 | Why? |
| Acrylates | 1 | 2018 | 34 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Thyroid Function Tests | 1 | 2019 | 200 | 0.05 | Why? |
| Cations | 1 | 2018 | 77 | 0.05 | Why? |
| Molecular Sequence Annotation | 1 | 2020 | 478 | 0.05 | Why? |
| Receptor, IGF Type 1 | 1 | 2017 | 24 | 0.05 | Why? |
| Femur Head | 1 | 2017 | 18 | 0.05 | Why? |
| Biomechanical Phenomena | 1 | 2019 | 291 | 0.05 | Why? |
| Acetabulum | 1 | 2017 | 18 | 0.05 | Why? |
| Molecular Weight | 1 | 2018 | 249 | 0.04 | Why? |
| Mice, Inbred ICR | 1 | 2018 | 242 | 0.04 | Why? |
| Picolinic Acids | 1 | 2017 | 6 | 0.04 | Why? |
| Nickel | 1 | 2018 | 55 | 0.04 | Why? |
| HT29 Cells | 1 | 2017 | 108 | 0.04 | Why? |
| Flow Cytometry | 1 | 2006 | 2393 | 0.04 | Why? |
| Antibiotics, Antineoplastic | 1 | 2018 | 128 | 0.04 | Why? |
| Joint Dislocations | 1 | 2017 | 37 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Hip Joint | 1 | 2017 | 59 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2019 | 184 | 0.04 | Why? |
| Mice | 4 | 2018 | 21357 | 0.04 | Why? |
| Platinum | 1 | 2017 | 54 | 0.04 | Why? |
| Ganciclovir | 1 | 2018 | 97 | 0.04 | Why? |
| Simplexvirus | 1 | 2018 | 124 | 0.04 | Why? |
| Directive Counseling | 1 | 2017 | 77 | 0.04 | Why? |
| RAW 264.7 Cells | 1 | 2018 | 316 | 0.04 | Why? |
| Neoplasm Staging | 2 | 2017 | 1999 | 0.04 | Why? |
| Young Adult | 5 | 2019 | 93724 | 0.04 | Why? |
| Thyroxine | 1 | 2019 | 250 | 0.04 | Why? |
| Range of Motion, Articular | 1 | 2017 | 168 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| Virus Replication | 1 | 2018 | 14331 | 0.04 | Why? |
| Mice, Inbred BALB C | 2 | 2018 | 5814 | 0.04 | Why? |
| Mice, Inbred C57BL | 2 | 2018 | 5542 | 0.04 | Why? |
| Nutrition Surveys | 1 | 2018 | 287 | 0.04 | Why? |
| Benzothiazoles | 1 | 2017 | 128 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Transcriptional Activation | 1 | 2017 | 196 | 0.04 | Why? |
| Doxorubicin | 1 | 2018 | 313 | 0.04 | Why? |
| Cells, Cultured | 2 | 2018 | 5835 | 0.04 | Why? |
| Micelles | 1 | 2015 | 96 | 0.04 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.04 | Why? |
| Surface Properties | 1 | 2017 | 448 | 0.04 | Why? |
| Phosphatidylinositol 3-Kinases | 1 | 2017 | 347 | 0.04 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.04 | Why? |
| Spondylitis, Ankylosing | 1 | 2017 | 231 | 0.04 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 372 | 0.04 | Why? |
| Cholesterol, HDL | 1 | 2018 | 439 | 0.04 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.04 | Why? |
| TOR Serine-Threonine Kinases | 1 | 2017 | 385 | 0.04 | Why? |
| Prodrugs | 1 | 2017 | 264 | 0.04 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 8811 | 0.03 | Why? |
| Diagnostic Errors | 1 | 2020 | 865 | 0.03 | Why? |
| Imaging, Three-Dimensional | 1 | 2019 | 680 | 0.03 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| NF-kappa B | 1 | 2020 | 1301 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2020 | 2275 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Biomarkers | 3 | 2021 | 23361 | 0.03 | Why? |
| Disease Vectors | 1 | 2014 | 208 | 0.03 | Why? |
| Carcinoma, Adenosquamous | 1 | 2011 | 17 | 0.03 | Why? |
| Waste Disposal, Fluid | 1 | 2012 | 60 | 0.03 | Why? |
| Particle Size | 1 | 2017 | 1052 | 0.03 | Why? |
| Vaccination | 1 | 2017 | 19050 | 0.03 | Why? |
| Serpins | 1 | 2011 | 67 | 0.03 | Why? |
| Carboplatin | 1 | 2011 | 76 | 0.03 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.03 | Why? |
| Infant | 3 | 2020 | 30274 | 0.03 | Why? |
| Cross-Sectional Studies | 4 | 2020 | 53120 | 0.03 | Why? |
| Heart | 1 | 2021 | 1791 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Paclitaxel | 1 | 2011 | 124 | 0.03 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.03 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.03 | Why? |
| Proteins | 1 | 2018 | 921 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Hysterectomy | 1 | 2011 | 171 | 0.03 | Why? |
| Antigens, Neoplasm | 1 | 2011 | 230 | 0.02 | Why? |
| Sentinel Surveillance | 1 | 2017 | 1093 | 0.02 | Why? |
| Reconstructive Surgical Procedures | 1 | 2019 | 860 | 0.02 | Why? |
| Autopsy | 1 | 2020 | 3495 | 0.02 | Why? |
| Lymphatic Metastasis | 1 | 2011 | 537 | 0.02 | Why? |
| CRISPR-Cas Systems | 1 | 2018 | 1397 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Adjuvants, Immunologic | 1 | 2018 | 1709 | 0.02 | Why? |
| Neoadjuvant Therapy | 1 | 2011 | 554 | 0.02 | Why? |
| Remission Induction | 1 | 2011 | 950 | 0.02 | Why? |
| Health Care Surveys | 1 | 2017 | 2942 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 13720 | 0.02 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.02 | Why? |
| Humidity | 1 | 2012 | 944 | 0.02 | Why? |
| Child, Preschool | 2 | 2020 | 36283 | 0.02 | Why? |
| Body Mass Index | 1 | 2018 | 4306 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Child | 3 | 2020 | 70012 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Bayes Theorem | 1 | 2014 | 3237 | 0.02 | Why? |
| Machine Learning | 1 | 2021 | 4395 | 0.02 | Why? |
| Adenocarcinoma | 1 | 2011 | 651 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Ultrasonography | 1 | 2019 | 4409 | 0.02 | Why? |
| Survival Rate | 1 | 2017 | 9206 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.01 | Why? |
| Cytokines | 1 | 2020 | 15010 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |